(Q45736946)

15 December 2017

title

MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT. (English)

1 reference

gastrointestinal stromal tumor

15 December 2017

1 reference

1 reference

Rong Fan

1

1 reference

15 December 2017

Jie Zhong

2

1 reference

15 December 2017

Sichang Zheng

3

1 reference

15 December 2017

Zhengting Wang

4

1 reference

15 December 2017

Ying Xu

5

1 reference

15 December 2017

Shuyi Li

6

1 reference

15 December 2017

Jie Zhou

7

1 reference

15 December 2017

Fei Yuan

8

1 reference

15 December 2017

language of work or name

1 reference

29 December 2013

1 reference

15 December 2017

1 reference

15 December 2017

volume

35

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

4209-4217

1 reference

Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Long-term efficacy of imatinib for treatment of metastatic GIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Gastrointestinal stromal tumor--background, pathology, treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

C-KIT signaling in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

The C-kit receptor-mediated signal transduction and tumor-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Tyrosine kinase inhibitors induce down-regulation of c-Kit by targeting the ATP pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF-κB activation in gastric tissues of diabetic gastroparesis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Briefing in family characteristics of microRNAs and their applications in cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

MicroRNAs in the axon and presynaptic nerve terminal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

miR-128 and its target genes in tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Pivotal role of microRNAs in cardiac physiology and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Emerging roles of microRNA in modulating cell-death processes in malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

The role of microRNAs in lung cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

MicroRNAs as therapeutic targets and their potential applications in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

MicroRNA control of epithelial-mesenchymal transition and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Cancer stem cells, microRNAs, and therapeutic strategies including natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Macro-role of microRNA in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1551-Z

Imatinib mesylate in clinically suspected gastric stromal tumors

21 January 2018

1 reference

12 December 2020

Gastrointestinal stromal tumor

1 reference

12 December 2020

Inpatient burden of gastrointestinal stromal tumors in the United States

1 reference

12 December 2020

SCF/KIT inhibition has a cumulative but reversible effect on the self-renewal of embryonic stem cells and on the survival of differentiating cells.

1 reference

12 December 2020

From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).

1 reference

12 December 2020

miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.

1 reference

12 December 2020

Novel role of microRNAs in prostate cancer

1 reference

12 December 2020

Targeted therapy in soft tissue sarcoma-a novel direction in therapeutics

1 reference

12 December 2020

miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma

1 reference

12 December 2020

Criminal or bystander: imatinib and second primary malignancy in GIST patients

1 reference

12 December 2020

The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification

1 reference

12 December 2020

Effectiveness of radiation therapy in GIST: A case report

1 reference

12 December 2020

Screening of differentially expressed microRNAs in borderline and malignant gastrointestinal stromal tumors

1 reference

12 December 2020

10.1007/S13277-013-1551-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

15 December 2017

1024854517

0 references

1 reference